157 research outputs found
Far-infrared all sky diffuse mapping with AKARI
We discuss the capability of AKARI in recovering diffuse far-infrared
emission, and examine the achieved reliability. Critical issues in making
images of diffuse emission are the transient response and long-term stability
of the far-infrared detectors. Quantitative evaluation of these characteristics
are the key to achieving sensitivity comparable to or better than that for
point sources (< 20 -- 95 MJy sr-1). We describe current activity and progress
toward the production of high quality images of the diffuse far-infrared
emission using the AKARI all-sky survey data.Comment: 4 pages, 8 figures, to appear in the Proceedings of the Conference
"AKARI, a light to illuminate the misty Universe", Fukutake Hall, The
University of Tokyo, Japan, 16-19 February 200
AKARI Far-Infrared All Sky Survey
We demonstrate the capability of AKARI for mapping diffuse far-infrared
emission and achieved reliability of all-sky diffuse map. We have conducted an
all-sky survey for more than 94 % of the whole sky during cold phase of AKARI
observation in 2006 Feb. -- 2007 Aug. The survey in far-infrared waveband
covers 50 um -- 180 um with four bands centered at 65 um, 90 um, 140 um, and
160 um and spatial resolution of 3000 -- 4000 (FWHM).This survey has allowed us
to make a revolutionary improvement compared to the IRAS survey that was
conducted in 1983 in both spatial resolution and sensitivity after more than a
quarter of a century. Additionally, it will provide us the first all-sky survey
data with high-spatial resolution beyond 100 um. Considering its extreme
importance of the AKARI far-infrared diffuse emission map, we are now
investigating carefully the quality of the data for possible release of the
archival data. Critical subjects in making image of diffuse emission from
detected signal are the transient response and long-term stability of the
far-infrared detectors. Quantitative evaluation of these characteristics is the
key to achieve sensitivity comparable to or better than that for point sources
(< 20 -- 95 [MJy/sr]). We describe current activities and progress that are
focused on making high quality all-sky survey images of the diffuse
far-infrared emission.Comment: To appear in Proc. Workshop "The Space Infrared Telescope for
Cosmology & Astrophysics: Revealing the Origins of Planets and Galaxies".
Eds. A.M. Heras, B. Swinyard, K. Isaak, and J.R. Goicoeche
The AKARI diffuse maps
We descibe the calibration of maps of diffuse Galactic Plane emission, and present detailed observations of several complexes. We put especial atention on Cygnus X region showing its temperature and density maps
A milestone to SPICA extragalactic surveys: The AKARI NEP survey
Large area surveys in the infrared wavelengths have revealed a significant evolution of the star formation activity of the universe in the past. The extragalactic sur- vey we have conduced with AKARI towards the north ecliptic pole (NEP) is unique, in terms of a comprehensive wavelength coverage from 2 to 24 micron using all 9 photometric bands of the Infrared Camera (IRC). We demonstrate that this IRC all-band photometry is capable of tracing a steep rise in the flux at the blue side of the polycyclic aromatic hydrocarbon (PAH) 6.2 micron emission feature of infrared luminous galaxies at z < 1. This allows us to estimate redshifts of mid-IR sources and identify `ultra-luminous starburst galaxies', based on mid-IR spectral energy distributions (SEDs). SPICA could inherit this unique capability of AKARI and extend the study to typical galaxy populations at z ~ 2, i.e. a critical period of galaxy formation
The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice
Host cell species-specific effect of cyclosporine A on simian immunodeficiency virus replication
<p>Abstract</p> <p>Background</p> <p>An understanding of host cell factors that affect viral replication contributes to elucidation of the mechanism for determination of viral tropism. Cyclophilin A (CypA), a peptidyl-prolyl <it>cis-trans </it>isomerase (PPIase), is a host factor essential for efficient replication of human immunodeficiency virus type 1 (HIV-1) in human cells. However, the role of cyclophilins in simian immunodeficiency virus (SIV) replication has not been determined. In the present study, we examined the effect of cyclosporine A (CsA), a PPIase inhibitor, on SIV replication.</p> <p>Results</p> <p>SIV replication in human CEM-SS T cells was not inhibited but rather enhanced by treatment with CsA, which inhibited HIV-1 replication. CsA treatment of target human cells enhanced an early step of SIV replication. CypA overexpression enhanced the early phase of HIV-1 but not SIV replication, while CypA knock-down resulted in suppression of HIV-1 but not SIV replication in CEM-SS cells, partially explaining different sensitivities of HIV-1 and SIV replication to CsA treatment. In contrast, CsA treatment inhibited SIV replication in macaque T cells; CsA treatment of either virus producer or target cells resulted in suppression of SIV replication. SIV infection was enhanced by CypA overexpression in macaque target cells.</p> <p>Conclusions</p> <p>CsA treatment enhanced SIV replication in human T cells but abrogated SIV replication in macaque T cells, implying a host cell species-specific effect of CsA on SIV replication. Further analyses indicated a positive effect of CypA on SIV infection into macaque but not into human T cells. These results suggest possible contribution of CypA to the determination of SIV tropism.</p
Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model
<p>Abstract</p> <p>Background</p> <p>Developing a quantitative understanding of viral kinetics is useful for determining the pathogenesis and transmissibility of the virus, predicting the course of disease, and evaluating the effects of antiviral therapy. The availability of data in clinical, animal, and cell culture studies, however, has been quite limited. Many studies of virus infection kinetics have been based solely on measures of total or infectious virus count. Here, we introduce a new mathematical model which tracks both infectious and total viral load, as well as the fraction of infected and uninfected cells within a cell culture, and apply it to analyze time-course data of an SHIV infection <it>in vitro</it>.</p> <p>Results</p> <p>We infected HSC-F cells with SHIV-KS661 and measured the concentration of Nef<it>-</it>negative (target) and Nef<it>-</it>positive (infected) HSC-F cells, the total viral load, and the infectious viral load daily for nine days. The experiments were repeated at four different MOIs, and the model was fitted to the full dataset simultaneously. Our analysis allowed us to extract an infected cell half-life of 14.1 h, a half-life of SHIV-KS661 infectiousness of 17.9 h, a virus burst size of 22.1 thousand RNA copies or 0.19 TCID<sub>50</sub>, and a basic reproductive number of 62.8. Furthermore, we calculated that SHIV-KS661 virus-infected cells produce at least 1 infectious virion for every 350 virions produced.</p> <p>Conclusions</p> <p>Our method, combining <it>in vitro </it>experiments and a mathematical model, provides detailed quantitative insights into the kinetics of the SHIV infection which could be used to significantly improve the understanding of SHIV and HIV-1 pathogenesis. The method could also be applied to other viral infections and used to improve the <it>in vitro </it>determination of the effect and efficacy of antiviral compounds.</p
Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors
<p>Abstract</p> <p>Background</p> <p>We investigated the interplay between complement and antibodies upon priming with single-cycle replicating viral vectors (SCIV) encoding SIV antigens combined with Adeno5-SIV or SCIV pseudotyped with murine leukemia virus envelope boosting strategies. The vaccine was applied via spray-immunization to the tonsils of rhesus macaques and compared with systemic regimens.</p> <p>Results</p> <p>Independent of the application regimen or route, viral loads were significantly reduced after challenge with SIVmac239 (p < 0.03) compared to controls. Considerable amounts of neutralizing antibodies were induced in systemic immunized monkeys. Most of the sera harvested during peak viremia exhibited a trend with an inverse correlation between complement C3-deposition on viral particles and plasma viral load within the different vaccination groups. In contrast, the amount of the observed complement-mediated lysis did not correlate with the reduction of SIV titres.</p> <p>Conclusion</p> <p>The heterologous prime-boost strategy with replication-deficient viral vectors administered exclusively via the tonsils did not induce any neutralizing antibodies before challenge. However, after challenge, comparable SIV-specific humoral immune responses were observed in all vaccinated animals. Immunization with single cycle immunodeficiency viruses mounts humoral immune responses comparable to live-attenuated immunodeficiency virus vaccines.</p
Nef Alleles from All Major HIV-1 Clades Activate Src-Family Kinases and Enhance HIV-1 Replication in an Inhibitor-Sensitive Manner
The HIV-1 accessory factor Nef is essential for high-titer viral replication and AIDS progression. Nef function requires interaction with many host cell proteins, including specific members of the Src kinase family. Here we explored whether Src-family kinase activation is a conserved property of Nef alleles from a wide range of primary HIV-1 isolates and their sensitivity to selective pharmacological inhibitors. Representative Nef proteins from the major HIV-1 subtypes A1, A2, B, C, F1, F2, G, H, J and K strongly activated Hck and Lyn as well as c-Src to a lesser extent, demonstrating for the first time that Src-family kinase activation is a highly conserved property of primary M-group HIV-1 Nef isolates. Recently, we identified 4-amino substituted diphenylfuropyrimidines (DFPs) that selectively inhibit Nef-dependent activation of Src-family kinases as well as HIV replication. To determine whether DFP compounds exhibit broad-spectrum Nef-dependent antiretroviral activity against HIV-1, we first constructed chimeric forms of the HIV-1 strain NL4-3 expressing each of the primary Nef alleles. The infectivity and replication of these Nef chimeras was indistinguishable from that of wild-type virus in two distinct cell lines (U87MG astroglial cells and CEM-T4 lymphoblasts). Importantly, the 4-aminopropanol and 4-aminobutanol derivatives of DFP potently inhibited the replication of all chimeric forms of HIV-1 in both U87MG and CEM-T4 cells in a Nef-dependent manner. The antiretroviral effects of these compounds correlated with inhibition of Nef-dependent activation of endogenous Src-family kinases in the HIV-infected cells. Our results demonstrate that the activation of Hck, Lyn and c-Src by Nef is highly conserved among all major clades of HIV-1 and that selective targeting of this pathway uniformly inhibits HIV-1 replication
Mechanisms of HIV-associated lymphocyte apoptosis: 2010
The inevitable decline of CD4T cells in untreated infection with the Human immunodeficiency virus (HIV) is due in large part to apoptosis, one type of programmed cell death. There is accumulating evidence that the accelerated apoptosis of CD4T cells in HIV infection is multifactorial, with direct viral cytotoxicity, signaling events triggered by viral proteins and aberrant immune activation adding to normal immune defense mechanisms to contribute to this phenomenon. Current antiviral treatment strategies generally lead to reduced apoptosis, but this approach may come at the cost of preserving latent viral reservoirs. It is the purpose of this review to provide an update on the current understanding of the role and mechanisms of accelerated apoptosis of T cells in the immunopathogenesis of HIV infection, and to highlight potential ways in which this seemingly deleterious process could be harnessed to not just control, but treat HIV infection
- …